x
Filter:
Filters applied
- JAH_Position_Papers
- Rapid CommunicationRemove Rapid Communication filter
- DiscussionRemove Discussion filter
- Middleman, Amy BRemove Middleman, Amy B filter
SAHM Position & Statement Papers
2 Results
- Position paper
Tetanus, Diphtheria, and Acellular Pertussis Vaccine: A Position Statement of the Society for Adolescent Medicine
Journal of Adolescent HealthVol. 45Issue 3p316–317Published in issue: September, 2009- Amy B. Middleman
- Ann Bruner
Cited in Scopus: 4Pertussis rates in the United States have been rising slowly since a nadir in 1976, and case rates have increased sharply in recent years. Although the Centers for Disease Control and Prevention reported over 25,000 cases in 2005, experts estimate that because of missed diagnoses, the actual burden of pertussis may be as high as 1 to 3 million cases per year [1]. In 2004, 38% of reported cases were among the 10- to-19-year-old age group [2]. - Position statement
Meningococcal vaccine: Position statement of the Society for Adolescent Medicine
Journal of Adolescent HealthVol. 37Issue 3p262Published in issue: September, 2005- Amy B. Middleman
- Vaughn I. Rickert
- Susan L. Rosenthal
Cited in Scopus: 1The incidence of meningococcal disease peaks during the neonatal years and again during the adolescent years. Most adolescent cases are vaccine preventable using the current tetravalent meningococcal vaccines. In February 2005, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention recommended routine immunization with the tetravalent conjugate meningococcal vaccine of all 11–12-year-olds, with the interim recommendation including all 14–15-year-olds, and special targeted populations to include incoming college freshmen living in dormitories, military recruits, certain travelers, microbiologists working with Neisseria meningitidis, and those with terminal complement component deficiencies and asplenia.
